var data={"title":"Folic acid: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Folic acid: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/6228?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=folic-acid-patient-drug-information\" class=\"drug drug_patient\">see &quot;Folic acid: Patient drug information&quot;</a> and <a href=\"topic.htm?path=folic-acid-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Folic acid: Pediatric drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6813283\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>FA-8 [OTC]</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173692\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Apo-Folic</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173733\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Vitamin, Water Soluble</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173695\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Megaloblastic and macrocytic anemias due to folate deficiency:</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Manufacturer&rsquo;s labeling:</i> Oral, IM, IV, SubQ: Initial: 0.4 to 1 mg/day. Higher doses may be required in resistant cases.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Maintenance dose: 0.4 mg/day</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Pregnant and lactating women: Maintenance dose: 0.8 mg/day</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Alternate recommendations (off-label dose):</i> Oral: 1 to 5 mg once daily (Cook 2014); doses up to 15 mg once daily have also been recommended (Hoffbrand 2015).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Prevention of neural tube defects (off-label use):</b> Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Females of childbearing potential: 400 to 800 mcg/day (USPSTF 2017)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Females at high risk, who have had a previous pregnancy with a neural tube defect, or with family history of neural tube defects: 4 mg/day (ACOG 2003)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173716\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=folic-acid-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Folic acid: Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Megaloblastic and macrocytic anemias due to folate deficiency:</b> Oral, IM, IV, SubQ: Initial: 0.4 to 1 mg/day. Higher doses may be required in resistant cases.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Maintenance dose: </i></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Infants: 0.1 mg/day</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Children &lt;4 years: Up to 0.3 mg/day</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Children &ge;4 years, Adolescents, and Adults: Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173696\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing. Vitamin B<sub>12</sub> deficiency must be ruled out before initiating folate therapy due to frequency of combined nutritional deficiencies.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173671\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Capsule, Oral [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">FA-8: 0.8 mg [dye free, sugar free, yeast free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 5 mg, 20 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Injection, as sodium folate: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 5 mg/mL (10 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 400 mcg, 800 mcg, 1 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet, Oral [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">FA-8: 800 mcg [dye free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 400 mcg, 800 mcg</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173657\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">Yes</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173675\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Oral preferred, but may also be administered by deep IM, SubQ, or IV injection.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">IV administration: May administer &le;5 mg dose undiluted over &ge;1 minute <b>or</b> may dilute &le;5 mg in 50 mL of NS or D<sub>5</sub>W and infuse over 30 minutes. May also be added to IV maintenance solutions and given as an infusion.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173674\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Megaloblastic and macrocytic anemias due to folate deficiency:</b> Treatment of megaloblastic and macrocytic anemias due to folate deficiency </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25725561\" class=\"block off-label drugH1Div\"><span class=\"drugH1\">Use: Off-Label</span>\n    <p>Adjunctive cofactory therapy in methanol toxicity (alternative to leucovorin calcium); Neural tube defects</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173740\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues: </span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Folic acid may be confused with folinic acid (leucovorin calcium)</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173664\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Frequency not defined. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cardiovascular: Flushing (slight)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Central nervous system: Malaise (general)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dermatologic: Erythema, pruritus, skin rash</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hypersensitivity: Hypersensitivity reaction</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Respiratory: Bronchospasm</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173679\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Hypersensitivity to folic acid or any component of the formulation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173661\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Anemia: Monotherapy: Not appropriate for monotherapy with pernicious, aplastic, or normocytic anemias when anemia is present with vitamin B<sub>12 </sub> deficiency. </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Pernicious anemia: Doses &gt;0.1 mg/day may obscure pernicious anemia with continuing irreversible nerve damage progression.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Aluminum: The parenteral product may contain aluminum; toxic aluminum concentrations may be seen with high doses, prolonged use, or renal dysfunction. Premature neonates are at higher risk due to immature renal function and aluminum intake from other parenteral sources. Parenteral aluminum exposure of &gt;4 to 5 mcg/kg/day is associated with CNS and bone toxicity; tissue loading may occur at lower doses (Federal Register, 2002). See manufacturer&rsquo;s labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse (AAP [&quot;Inactive&quot; 1997]; CDC, 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors, 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer&rsquo;s labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Resistance to treatment: May occur with depressed hematopoiesis, alcoholism, and deficiencies of other vitamins. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13299358\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173665\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=8475&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Fosphenytoin: Folic Acid may decrease the serum concentration of Fosphenytoin. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Green Tea: May decrease the serum concentration of Folic Acid.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">PHENobarbital: Folic Acid may decrease the serum concentration of PHENobarbital. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Phenytoin: Folic Acid may decrease the serum concentration of Phenytoin. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Primidone: Folic Acid may decrease the serum concentration of Primidone. Additionally, folic acid may decrease concentrations of active metabolites of primidone (e.g., phenobarbital). <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Raltitrexed: Folic Acid may diminish the therapeutic effect of Raltitrexed. <i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">SulfaSALAzine: May decrease the serum concentration of Folic Acid.<i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173668\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">A (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173683\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Water soluble vitamins cross the placenta. Folate requirements increase during pregnancy. Folate supplementation during the periconceptual period decreases the risk of neural tube defects (ACOG 2003; USPSTF 2009). Folate supplementation (doses larger than the RDA) is recommended for women who may become pregnant (IOM 1998). Folic acid is also indicated for the treatment of anemias due to folate deficiency in pregnant women.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F14191848\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Folate is excreted in breast milk; concentrations are not affected by dietary intake unless the mother has a severe deficiency. Folate requirements increase in breast-feeding women (IOM 1998). </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173684\" class=\"block dic drugH1Div\"><span class=\"drugH1\">Dietary Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">As of January 1998, the FDA has required manufacturers of enriched flour, bread, corn meal, pasta, rice, and other grain products to add folic acid to their products. The intent is to help decrease the risk of neural tube defects by increasing folic acid intake. Other foods which contain folic acid include dark green leafy vegetables, citrus fruits and juices, and lentils.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">\n      <b>Dietary adequate intake (AI)</b> (IOM 1998): Expressed as folate equivalents:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">1 to 6 months: 65 mcg/day</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">7 to 12 months: 80 mcg/day</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dietary recommended daily allowance (RDA)</b> (IOM 1998): Expressed as dietary folate equivalents:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">1 to 3 years: 150 mcg/day</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">4 to 8 years: 200 mcg/day</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">9 to 13 years: 300 mcg/day</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&gt;13 years: 400 mcg/day</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pregnancy: 600 mcg/day</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Lactation: 500 mcg/day</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173672\" class=\"block rer drugH1Div\"><span class=\"drugH1\">Reference Range</span>\n    <p style=\"text-indent:0em;display:inline\">Therapeutic: 0.005-0.015 mcg/mL</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173660\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Folic acid is necessary for formation of a number of coenzymes in many metabolic systems, particularly for purine and pyrimidine synthesis; required for nucleoprotein synthesis and maintenance in erythropoiesis; stimulates WBC and platelet production in folate deficiency anemia. Folic acid enhances the metabolism of formic acid, the toxic metabolite of methanol, to nontoxic metabolites (off-label use).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173678\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Onset of action: Peak effect: Oral: 0.5-1 hour </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: Proximal part of small intestine</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Metabolism: Hepatic</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Bioavailability: Oral: Folic acid supplement: ~100%; In presence of food: 85%; Dietary folate: 50% (IOM 1998) </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Time to peak: Oral: 1 hour</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Urine</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173682\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Capsules</b> (FA-8 Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">0.8 mg (100): $3.78</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Capsules</b> (Folic Acid Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5 mg (100): $7.20</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">20 mg (100): $8.40</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Folic Acid Injection)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5 mg/mL (10 mL): $54.14</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (FA-8 Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">800 mcg (100): $3.78</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Folic Acid Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1 mg (100): $35.99</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">400 mcg (100): $2.34</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">800 mcg (100): $3.35</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F173685\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>A.F. Valdecasas (MX);</li>\n      <li>Acfol (ES, PT);</li>\n      <li>Acide Folique CCD (FR);</li>\n      <li>Acido Folico (AR, CO, EC, PE);</li>\n      <li>Acido Folico Fada (AR);</li>\n      <li>Acifol (AR);</li>\n      <li>Anemolat (ID);</li>\n      <li>Apo-Folic (NZ);</li>\n      <li>Bio-Folic (BE);</li>\n      <li>Clonfolic (IE);</li>\n      <li>Conacid (AR);</li>\n      <li>Elvefocal (AR);</li>\n      <li>Endofolin (BR);</li>\n      <li>Enhansid (PH);</li>\n      <li>Feri (PH);</li>\n      <li>Filicine (GR, MT);</li>\n      <li>Fionat (ID);</li>\n      <li>Folac (BD);</li>\n      <li>Folacid (PL);</li>\n      <li>Folacin (BR, HR, RU, SE, TW);</li>\n      <li>Folart (PH);</li>\n      <li>Folate (BD);</li>\n      <li>Folavit (BE, LU);</li>\n      <li>Folbiol (TR);</li>\n      <li>Folee-1 (LK);</li>\n      <li>Foli 5 (IL);</li>\n      <li>Foliage (PH);</li>\n      <li>Foliamin (HK, JP, TH);</li>\n      <li>Folic Acid DHA (MY);</li>\n      <li>Folic Acid Pharm Ecologist (AR);</li>\n      <li>Folicare (BH);</li>\n      <li>Folicid (KR);</li>\n      <li>Folicil (CY, HK, MT, PT);</li>\n      <li>Folicum (AE, BH, KW, QA, SA);</li>\n      <li>Folimax (PH);</li>\n      <li>Folimen (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Folimet (DK);</li>\n      <li>Folin (BR);</li>\n      <li>Folina (IT, MY);</li>\n      <li>Folinsyre &rdquo;Dak&rdquo; (DK);</li>\n      <li>Foliphar (BE);</li>\n      <li>Folitab (QA);</li>\n      <li>Folivit (TH);</li>\n      <li>Folivita (SA);</li>\n      <li>Folivital (MX);</li>\n      <li>Foloicare (AE);</li>\n      <li>Folsan (AT, HR);</li>\n      <li>Folsyre (NO);</li>\n      <li>Folverlan (DE);</li>\n      <li>Folvite (AE, BB, BH, BM, BS, BZ, CH, CY, EG, FI, GY, IL, IQ, IR, JM, JO, KW, LB, LY, NL, OM, SA, SR, SY, TT, YE);</li>\n      <li>Gravi-Fol (DE);</li>\n      <li>Gravida (BE);</li>\n      <li>Huma-Folacid (HU);</li>\n      <li>Ingafol (IN, LK);</li>\n      <li>Lexpec (GB);</li>\n      <li>Megafol (AU);</li>\n      <li>Mithra Folic (BE);</li>\n      <li>Nufolic (ID);</li>\n      <li>Prinac AC (MX);</li>\n      <li>Quatro (ID);</li>\n      <li>RubieFol (DE);</li>\n      <li>Tecnovorin (BR);</li>\n      <li>Tesha-1 (LK);</li>\n      <li>Tonixan (PY);</li>\n      <li>Travital Folic Acid (BE);</li>\n      <li>Tyfol (UA);</li>\n      <li>Vifolin (AE, BH, CY, EG, IL, IQ, IR, JO, KW, LB, LY, OM, SA, SY, YE)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    ACOG Committee on Practice Bulletins, &quot;ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 44, July 2003. (Replaces Committee Opinion Number 252, March 2001),&quot; <i>Obstet Gynecol</i>, 2003, 102(1):203-13.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/folic-acid-drug-information/abstract-text/12850637/pubmed\" target=\"_blank\" id=\"12850637\">12850637</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/folic-acid-drug-information/abstract-text/11487763/pubmed\" target=\"_blank\" id=\"11487763\">11487763</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Aluminum in large and small volume parenterals used in total parenteral nutrition. <i>Fed Regist</i>. 2002;67(244):77792-77793. To be codified at 21 CFR &sect;201.323.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"12216995\"></a>Barceloux DG, Bond GR, Krenzelok EP, et al, &ldquo;American Academy of Clinical Toxicology Practice Guidelines on the Treatment of Methanol Poisoning,&rdquo; <i>J Toxicol Clin Toxicol</i>, 2002, 40(4):415-46.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/folic-acid-drug-information/abstract-text/12216995/pubmed\" target=\"_blank\" id=\"12216995\">12216995</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bibbins-Domingo K, Grossman DC, Curry SJ, et al; US Preventive Services Task Force. Folic acid supplementation for the prevention of neural tube defects: US Preventive Services Task Force recommendation statement. <i>JAMA</i>. 2017;317(2):183-189. doi: 10.1001/jama.2016.19438.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/folic-acid-drug-information/abstract-text/28097362/pubmed\" target=\"_blank\" id=\"28097362\">28097362</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol&mdash;United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href=\"http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm\" target=\"_blank\">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a><span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/folic-acid-drug-information/abstract-text/6810084/pubmed\" target=\"_blank\" id=\"6810084\">6810084</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cook K, Lyons WL. Chapter 80. Anemias. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey L. eds. <i>Pharmacotherapy: A Pathophysiologic Approach, 9e</i>. New York, NY: McGraw-Hill; 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Davis RE, &ldquo;Clinical Chemistry of Folic Acid,&rdquo; <i>Adv Clin Chem</i>, 1986, 25:233-94.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/folic-acid-drug-information/abstract-text/3087140/pubmed\" target=\"_blank\" id=\"3087140\">3087140</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Department of Health and Human Services, Food and Drug Administration, Nutrition Labeling, <i>Fed Regist</i>, 1980, 45:69043.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Folic acid [prescribing information]. Schaumburg, IL: APP Pharmaceuticals, LLC; August 2011.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Gahart BL and Nazareno AR, <i>2014 Intravenous Medications: A Handbook for Nurses and Health Professionals</i>, 30th ed, St Louis, MO: Elsevier/Mosby, 2014, 547-48.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hoffbrand A. Megaloblastic Anemias. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. eds.<i> Harrison's Principles of Internal Medicine, 19e</i>. New York, NY: McGraw-Hill; 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/folic-acid-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    IOM (Institute of Medicine), <i>Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B</i><sub>6</sub><i>, Folate, Vitamin B</i><sub>12</sub><i>, Pantothenic Acid, Biotin and Choline</i>, Washington, DC: National Academy Press, 1998.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lambie DG and Johnson RH, &ldquo;Drugs and Folate Metabolism,&rdquo; <i>Drugs</i>, 1985, 30(2):145-55.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/folic-acid-drug-information/abstract-text/3896745/pubmed\" target=\"_blank\" id=\"3896745\">3896745</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lange H, Suryapranata H, De Luca G, et al, &ldquo;Folate Therapy and In-Stent Restenosis After Coronary Stenting,&rdquo; <i>N Engl J Med</i>, 2004, 350(26):2673-81.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/folic-acid-drug-information/abstract-text/15215483/pubmed\" target=\"_blank\" id=\"15215483\">15215483</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lewis DP, Van Dyke DC, Willhite LA, et al, &ldquo;Phenytoin-Folic Acid Interaction,&rdquo; <i>Ann Pharmacother</i>, 1995, 29(7-8):726-35.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/folic-acid-drug-information/abstract-text/8520091/pubmed\" target=\"_blank\" id=\"8520091\">8520091</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Liem A, Reynierse-Buitenwerf GH, Zwinderman AH, et al, &ldquo;Secondary Prevention With Folic Acid: Effects on Clinical Outcomes,&rdquo; <i>J Am Coll Cardiol</i>, 2003, 41(12):2105-13.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/folic-acid-drug-information/abstract-text/12821232/pubmed\" target=\"_blank\" id=\"12821232\">12821232</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Olszewski AJ, Szostak WB, Bialkowska M, et al, &ldquo;Reduction of Plasma Lipid and Homocysteine Levels by Pyridoxine, Folate, Cobalamin, Choline, Riboflavin, and Troxerutin in Atherosclerosis,&rdquo; <i>Atherosclerosis</i>, 1989, 75(1):1-6.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/folic-acid-drug-information/abstract-text/2930611/pubmed\" target=\"_blank\" id=\"2930611\">2930611</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Savage DG and Lindenbaum J, &ldquo;Folate-Cobalamin Interactions,&rdquo; Bailey LB, ed, <i>Folate in Health and Disease</i>, New York: Marcel Dekker, Inc, 1995, 237-85.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Schnyder G, Roffi M, Flammer Y, et al, &ldquo;Effect of Homocysteine-Lowering Therapy With Folic Acid, Vitamin B12, and Vitamin B6 on Clinical Outcome After Percutaneous Coronary Intervention: The Swiss Heart Study: A Randomized Controlled Trial,&rdquo; <i>JAMA</i>, 2002, 288(8):973-9.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/folic-acid-drug-information/abstract-text/12190367/pubmed\" target=\"_blank\" id=\"12190367\">12190367</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 8475 Version 189.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F6813283\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F173692\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F173733\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F173695\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F173716\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F173696\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F173671\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F173657\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F173675\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F173674\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Use: Off-Label\" href=\"#F25725561\" class=\"outlineLink\">Use: Off-Label</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F173740\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F173664\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F173679\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F173661\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13299358\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F173665\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F173668\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F173683\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F14191848\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Dietary Considerations\" href=\"#F173684\" class=\"outlineLink\">Dietary Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Reference Range\" href=\"#F173672\" class=\"outlineLink\">Reference Range</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F173660\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F173678\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F173682\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F173685\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/8475|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=folic-acid-patient-drug-information\" class=\"drug drug_patient\">Folic acid: Patient drug information</a></li><li><a href=\"topic.htm?path=folic-acid-pediatric-drug-information\" class=\"drug drug_pediatric\">Folic acid: Pediatric drug information</a></li></ul></div></div>","javascript":null}